$AMZN

Amazon.com Inc.

  • NASDAQ
  • Retail Trade
  • Internet Retail

PRICE

$93.57 โ–ฒ0.107%

Extented Hours

VOLUME

35,088,609

DAY RANGE

93.32 - 94.28

52 WEEK

85.87 - 179.8

Join Discuss about AMZN with like-minded investors

profile
@dros #droscrew
recently

$AMZN Nov25 98 C $MMAT Dec02 2 C $LYFT Nov25 10.5 C $ABBV Nov25 162.5 C $CHPT Nov25 12 C $LYFT Feb 12.5 C $RIG Feb 5 C $SHOP Dec 41.5 C $GSAT Jan 2 C $CCJ Dec 26 C $MP Mar 35 C $ONON Apr 20 C $AMAT Nov25 108 C $LYFT Jan12.5/15 C

105 Replies 7 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

RECAP 11/22 Unusual Calls: $AMZN Nov25 98 C $MMAT Dec02 2 C $LYFT Nov25 10.5 C $ABBV Nov25 162.5 C $CHPT Nov25 12 C $LYFT Feb 12.5 C $RIG Feb 5 C $SHOP Dec 41.5 C $GSAT Jan 2 C $CCJ Dec 26 C $MP Mar 35 C $ONON Apr 20 C $AMAT Nov25 108 C $LYFT Jan12.5/15 C

67 Replies 10 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

RECAP 11/21 Unusual Calls: $AMZN Dec09 110 C $LI Nov25 19 C $ACN Dec 320 C $BHC Dec30 7.5 C $COP Dec 145 C $QFIN Dec 15 C $META Jan-24 230 C $T Apr 21 C

137 Replies 6 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

$AMZN Dec09 110 C $LI Nov25 19 C $ACN Dec 320 C $BHC Dec30 7.5 C $COP Dec 145 C $QFIN Dec 15 C $META Jan-24 230 C $T Apr 21 C

110 Replies 14 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

1.3 million $AMZN @92.71

126 Replies 11 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

so many big blocks in $AMZN this last while..... either its getting ready to rip...or folks want out before the big one

130 Replies 13 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

couple of 1mill blocks of $AMZN at 96.06 and 96

44 Replies 13 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

AMAZON $AMZN IS RAISING OUTBOUND FULFILLMENT FEE RATES BY $0.22 ON AVERAGE

141 Replies 10 ๐Ÿ‘ 12 ๐Ÿ”ฅ

SC
@scottz #droscrew
recently

$AMZN is it headed for the gap at 109 this week probably

115 Replies 12 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

$AMZN 1 mill @102.42

150 Replies 8 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

$amzn 700k @99.75

53 Replies 12 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

$AMZN 800k @99.35

131 Replies 13 ๐Ÿ‘ 10 ๐Ÿ”ฅ

SC
@scottz #droscrew
recently

$AMZN Bezos urges consumers and business owners to reduce risk in the face of a likely recession

118 Replies 7 ๐Ÿ‘ 7 ๐Ÿ”ฅ

SC
@scottz #droscrew
recently

amzn someone in on nov 18 100 calls 20k of them

117 Replies 11 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

AMZN really had to scale up quickly for the pandemic

75 Replies 9 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

$AAPL Feb 150 C $AMZN Dec 105 C $ALLY Jan 30 C $LVS Nov 43/45 C Spd $F Jan 15 C $ARKK Dec02 41 C $BHC Dec 8 C $ALKS Jan-24 35 C $UMC Dec 7.5 C $CVNA Nov11 10 C

87 Replies 13 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

RECAP 11/10 Unusual Calls: $AAPL Feb 150 C $AMZN Dec 105 C $ALLY Jan 30 C $LVS Nov 43/45 C Spd $F Jan 15 C $ARKK Dec02 41 C $BHC Dec 8 C $ALKS Jan-24 35 C $UMC Dec 7.5 C $CVNA Nov11 10 C

41 Replies 11 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

Intraday Option Volumes $SPY 5.572m (42% call/58% put) $TSLA 2.085m (53% call/47% put) $AMZN 1.998m (70% call/30% put) $QQQ 1.937k (49% call/51% put) $AAPL 1.193m (54% call/46% put) $META 756k (60% call/40% put) $IWM 737k (27% call/73% put) $TQQQ 569k (65% call/35% put)

88 Replies 12 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

1.1 mill $AMZN @95.8

124 Replies 13 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

this orgy of buying on $AMZn i suppoose means all the big trades the other day was bullish

40 Replies 14 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

i am also short $AMZn but that hasnt worked just as well ... crypto looks broken

55 Replies 11 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

probably the three most expensive stocks are AMZN,NVDA,TSLA all huge puts at 1.37-1.40PM today

75 Replies 9 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

AMZN is still a very epensive stock at 60 x next year earnings as i ponted out this am

103 Replies 11 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

$big trades all day in $amzn STOCK ... amazon chart looks like it hasnt been able to get out of its own way....very weak during recovery.... massive puts in it

109 Replies 8 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

PPL AT SAMETIME as amzn 1.40 today about $80 mill ITM PUTS

89 Replies 8 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

another 1 mill $AMZN at 88.58

132 Replies 7 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

all these huge money trades in $AMZn were bearish it appears

133 Replies 8 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

i notice something similar on 3rd and 2nd... huge deep in the money puts..... seems odd but i dont follow $amzn MUCH.....IS THIS ODD BEHAVIOUR?

57 Replies 9 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

AMZN puts in $100s of million all at similar time

124 Replies 8 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

1 million $AMZN @90.31

74 Replies 14 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

ANOTHER 1 MILL $AMZN 91.03

72 Replies 13 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

amzn is 60 I THINK...AND $tslA usually beats ..... starting to look very decent

145 Replies 11 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

TSLA p/e ratio NOW SIGNIFICANTLY LOWER THAN $AMZN. tESLA FWD pe IS ONLY 35

64 Replies 11 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

1.1 mill $AMZN @91.04

139 Replies 9 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

3.2 Mil $AMZN @ 90.85

114 Replies 11 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

$AR Nov 37 C $WBD Dec 17.5 C $BABA Dec02 78 C $AMZN Jun-24 80 C $RKT Nov04 6.5 C

146 Replies 15 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

RECAP 11/3 Unusual Calls: $AR Nov 37 C $WBD Dec 17.5 C $BABA Dec02 78 C $AMZN Jun-24 80 C $RKT Nov04 6.5 C

46 Replies 12 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@thegiz18 #ivtrades
recently

$AMZN failing

50 Replies 14 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@Marcosx #ivtrades
recently

you must think AMZN will look below and fail ballsy move GL

119 Replies 15 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@cespinoza9801 #ivtrades
recently

bought $Amzn at 96.05

120 Replies 13 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@lucullus #droscrew
recently

Summary Cano Health currently presents an interesting investment opportunity with a potential short-term 58% upside. Recently, rumors appeared that Cano Health has received acquisition interest, with healthcare industry giants CVS Health, Humana and UnitedHealth among the rumored buyers. Given ongoing pressure from two prominent activists and industry consolidation trends, I expect a company sale to be announced shortly. Looking for more investing ideas like this one? Get them exclusively at Special Situation Investing. Learn More ยป Health visitor and a senior woman during nursing home visit A Potential company sale might be brewing up behind the scenes. Cano Health (NYSE:CANO) owns and operates senior primary care health centers in nine US states, with a primary focus on Florida. Recently, Bloomberg, Reuters and WSJ reported that the company has received acquisition interests, with health industry giants Humana (HUM), UnitedHealth (UNH) and CVS Health (CVS) mentioned as the front-runners to buyout CANO. Acquisition rumors follow activism from several of CANO's shareholders. In March, Daniel Loeb's Third Point (2.2% of voting power) started to push the company towards strategic alternatives, arguing that CANO should address the value gap (arising from the company going public through a SPAC) by initiating a company sale. Then, in August, Owl Creek Asset Management (owns 1%) delivered a letter, also considering the company undervalued versus peers and industry transactions. As it stands, it seems that the management/insiders (who own 55%) have been under pressure from two prominent activists to sell the company. Not surprisingly, in August, CANO's management stated that the company is open to all strategic alternatives and has hired financial advisors. Reportedly, the second round of discussions is currently ongoing, with the deal possibly finalized in the upcoming weeks. Reports do not mention the acquisition price, however, peer/transaction multiples (also mentioned by the activist Owl Creek) suggest $14/share might be a reasonable price tag - this would imply a 58% upside from current levels. Buyout rumors come amid broader healthcare industry consolidation trends as large healthcare insurers are scooping up healthcare providers in an effort to combine insurance and healthcare provider activities. The industry is currently in a shift towards value based care - a model where providers are paid based on patient health outcomes (as opposed to the traditional fee-for-service model where patients pay for each service rather than outcome). Naturally, the value-based care model closely aligns the interests of both health insurance firms and healthcare providers. Numerous industry executives, including Humana's Medicare President, have noted that value-based model has benefits for providers/insurers, including noticeably higher contribution margins, thus pushing up incentives for consolidation. Not surprisingly, these dynamics have spurred a number of acquisitions of healthcare providers by major health insurers. CVS is currently buying health care platform provider Signify Health (Sep'22), UNH is scooping up home care provider LHC Group (announced in Mar'22) and HUM has already acquired home healthcare provider Kindred at Home (Aug'21). The industry has also seen increasing M&A activity from non-insurers entering the space, including Amazon (AMZN) acquiring primary care company One Medical (announced in Jul'22, by the way CVS was one of the bidders there as well) and Walgreens Boots Alliance (WBA) purchasing a majority stake in primary care provider VillageMD (Oct'21). These dynamics and the fact that CANO might be an attractive target have also been recently reiterated by CANO's CEO: I expect continued consolidation and acceleration in the paradigm shift of value-based care. And what this means for us is yet another validation of how attractive our asset is and the industry as a whole. A Potential acquisition would make strategic sense for either of the rumored buyers HUM, UNH or CVS given CANO's extensive presence in Florida's primary care market. CANO is reportedly the largest independent value-based primary care provider to Medicare/Medicaid patients in the state. Meanwhile, three potential suitors currently rank as the three largest primary care insurers in the Florida. Humana and Cano have seemingly deep ties - HUM has been invested in Cano Health prior to CANO's IPO and still owns an undisclosed stake. Currently, CANO is HUM's biggest independent primary care provider in Florida. Interestingly, as part of their earlier agreement, HUM has a right of first refusal, meaning that HUM can match any acquisition offer made for CANO. Notably, HUM has significantly expanded its investment in primary senior care in the last five years, recently stating that the TAM is very large at $700bn. As part of its joint venture with PE firm Welsh Carson, Humana now aims to open 100 new CenterWell senior primary care clinics in the next three years. From the CEO's remarks during Q2'22 earnings call: We do see some great opportunity today, both CenterWell primary care and the home are agnostic and continue to see great growth, serving both other payers and other parts of the Medicare system. And at the same time, we're also seeing opportunity within our primary - within our pharmacy area to offer some agnostic opportunities there. So the ability for it to integrate and also to expand beyond the Medicare side of the business is really at the heart of what you see us more formally creating the CenterWell service side, while on the insurance side, continuing to leverage the efficiencies across the various different insurance platforms. Meanwhile, CVS's management, in addition to the recent acquisition of Signify Health, has recently stated that their priority is the same - to expand into the primary care segment: From Morgan Stanley Healthcare Conf: Well I think we are urging, obviously - we're very urging, I just ask our teams and I think if you think about our strategy, really we've been very clear that we want to extend into care delivery and we're starting with Signify. We can't always determine the order. Obviously primary care is something we believe we need to advance because we really want to enable consumers to have a differentiate experience and improve health outcomes. So we're playing our game. From the CVS Q2'22 earnings call: As you would expect, we are being very disciplined both strategically and financially, as we pursue kind of our M&A strategy. We can't be in the primary care without M&A. We've been very clear about that. Valuation Chart Comp Filings At current price levels, CANO seems undervalued on a TTM/2022E revenue basis relative to larger peers OSH (also owns and operates primary care centers) and AGL (runs primary care physician networks so not as comparable). Moreover, recently announced ONEM and SGFY acquisitions were done at noticeably higher multiples. Activist Owl Creek notes the following reasons for why CANO might be trading at a discount to peers/industry transactions: Unfortunately, Cano has consistently traded at a discount to its peers due to its SPAC heritage, its hybrid model (owned and operated medical centers along with affiliates), and heavy concentration in the South Florida market. One could argue for some discount due to one or more of these factors, but the valuation discrepancy between Cano and peers is highly punitive. Another activist Third Point also agrees that the undervaluation is explained by both SPAC heritage and the company's shareholder base (given dual class structure and high insider ownership): However given recent developments at the Issuer and taking into account the market's largely unfavorable view of companies taken public through special purpose acquisition vehicles, the Reporting Persons believe the Board of Directors should immediately engage financial and legal advisors to commence a review of strategic alternatives. [โ€ฆ] The Reporting Persons believe this strategic review should focus on a sale of the Issuer, and that a properly run sales process is likely to result in offers representing a substantial premium to the Issuer's trading price. The Reporting Persons believe that the Issuer is unlikely to achieve such valuation on a stand-alone basis, in part due to structural issues with its shareholder base. The activist Owl Creek has stated that CANO has been undervalued by the market despite having higher 2022E revenues than both OSH/AGL and being on track to exceed 2022 membership/revenue/EBITDA guidance. Using a 3x revenue multiple based on peers OSH/AGL and Amazon's acquisition of ONEM, Owl Creek arrives at an acquisition price tag of $14/share. The markets have moved down a bit since the letter was written, so a 3x multiple would now translate to a $13/share price. More background on CANO Historical financials are provided below: Table Company Filings Financially, since going public in 2020, CANO has managed to record high revenue growth - 93% in 2021. Notably, the growth has to a large degree been driven by acquisitions, including purchase of University Health Care and Doctor's Medical Center for a total of $900m (announced in Jun'21 and Jul'21). This has allowed the company to significantly increase its patient base as number of memberships has expanded from 156k to 282k over the last year. That said, the business is yet to turn profitable and is still burning cash - $135m in 2021 operating losses. From a liquidity perspective, the company is quite highly levered with $878m in net debt (compared to $4.2bn market cap). Given CANO's business model, the company needs extensive capital to accelerate further growth. At current share price levels, any equity raise would seem highly dilutive given that even after the buyout rumors the stock trades below pre-2022 levels of $9-$16/share. CANO's shares are rather tightly held with 55% of the voting power (Class A + Class B shares) held by the management + insiders. CANO went public in 2020 through a SPAC backed by Starwood Capital CEO Barry Sternlicht who now holds 9% voting power. Another 33% of total shares are owned by a PE firm InTandem Capital Partners which has backed the company since 2016. Both Sternlicht and InTandem's managing partner Elliot Cooperstone currently sit on CANO's board. Interestingly, Cooperstone was previously the CEO of Prodigy Health Group which was acquired by Aetna, a subsidiary of CVS Health. Another 17% are held by six institutional investors, including FMR (7%), BlackRock (3%) and Millennium Asset Management (2%), among others. Risks According to the activist Owl Creek, last year CVS stated that the company had well over $10bn to deploy towards strategic initiatives related to value-based care. With the SGFY acquisition, the company will spend around $7bn, potentially implying that the management might not be willing to pursue another large acquisition. This risk, however, seems limited given CVS's overall large gross cash position ($15bn in cash + investments) and the fact that SGFY captures a slightly different market niche than CANO - it is a healthcare platform which does not own and operate health centers. Management/insiders not agreeing to sell their stake. That said, considering prominent activist pressure, current market turbulence and the fact that the company is yet to inflect towards profitability, an offer at $14/share - a share price close to 2021 highs - could seal the deal. Conclusion CANO presents a very interesting investment opportunity with a short potential timeline. I believe that prominent activist involvement and industry consolidation dynamics point to a company sale brewing up behind the scenes. Importantly, risk/reward seems to be highly favorable here, suggesting that investors might consider CANO as a long position in their portfolios.

78 Replies 11 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@cespinoza9801 #ivtrades
recently

waiting for 96.05 to buy $amzn

63 Replies 14 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

$BEKE Jan 15 C $AMZN Nov 103 C $AA Mar 45/50 C Spd $NCLH Nov04 16.5 C $WBA Nov04 37.5 C $RITM Nov 9 C $COP Nov 145 C $XPEV Mar 10 C $DVN Nov 90 C

95 Replies 15 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

RECAP 10/28 Unusual Calls: $BEKE Jan 15 C $AMZN Nov 103 C $AA Mar 45/50 C Spd $NCLH Nov04 16.5 C $WBA Nov04 37.5 C $RITM Nov 9 C $COP Nov 145 C $XPEV Mar 10 C $DVN Nov 90 C

125 Replies 14 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@NoobBot #Crypto4Noobs
recently

**howardlindzon:** Only $AAPL left standing of large cap tech โ€ฆ maybe they buy $SHOP to stick it to $AMZN next โ€ฆ chime in (long all 3) https://twitter.com/howardlindzon/status/1586070176990384128

131 Replies 9 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

Intraday Option Volumes $SPY 5.393m (43% call/57% put) $AAPL 2.162m (50% call/50% put) $AMZN 1.941m (54% call/46% put) $QQQ 1.788m (40% call/60% put) $TSLA 1.707m (55% call/45% put) $META 842k (68% call/32% put) $IWM 556k (32% call/68% put) $NVDA 409k (56% call/44% put)

89 Replies 10 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@cespinoza9801 #ivtrades
recently

I'm in $goog and $Amzn calls

116 Replies 7 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@thegiz18 #ivtrades
recently

$META and $AMZN trying to regain $100 level

110 Replies 12 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@thegiz18 #ivtrades
recently

Good morning, US stock futures are flat to negative. Techs with relative weakness while Small Caps and Dow showing relative strength. Dollar rising off recent pullback, 10yr ticking back above 4% Gold and Silver lower by about 1% Crude and NG also about 1% lower $AMZN down 12% on forecast, but off last nights lows $AAPL shook off initial earnings drop $PINS, $INTC nice jumps on earnings China names again in the dumps More earnings on tap this morning along with some economic news before the open Trade Well

137 Replies 6 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@AJAJ #droscrew
recently

but you wanted 120 Nav > @Navneet said: im happy $amzn dumped

97 Replies 8 ๐Ÿ‘ 11 ๐Ÿ”ฅ

Key Metrics

Market Cap

0.95 T

Beta

1.61

Avg. Volume

105.71 M

Shares Outstanding

10.20 B

Yield

0%

Public Float

0

Next Earnings Date

2023-02-02

Next Dividend Date

Company Information

Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon.

CEO: Andy Jassy

Website:

HQ: 410 Terry Ave N Seattle, 98109-5210 Washington

Related News